These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3698835)

  • 21. [Specific hyposensitization using pyridine extracts precipitated with aluminum. III. Intolerance to the extracts. Anatomo-pathological study of the receptor area].
    Basomba A; Tamarit L; Peláez A; Villalmanzo IG
    Allergol Immunopathol (Madr); 1974; 2(5):325-32. PubMed ID: 4218447
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyposensitization in allergic seasonal rhinitis as evaluated by rhinomanometry.
    Irander K; Olofsson J; Aschan G
    Acta Otolaryngol Suppl; 1979; 360():24-6. PubMed ID: 287345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Side reactions furing specific desensitization to pollen allergy].
    Schuchardt P; Hühnerfuss S
    Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1196-9. PubMed ID: 4791837
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prospective study of the undesirable effects of allergic desensitization].
    Badan M; Fasel-Felley J; Kolly M; Frei PC; Pécoud A
    Schweiz Med Wochenschr; 1986 Feb; 116(8):243-5. PubMed ID: 3952481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contribution of allergen immunotherapy using Phostal in the treatment of seasonal allergic rhinitis (two years of use)].
    Bartosíková L; Necas J; Bartosík T; Pavlík M; Fránová J
    Ceska Slov Farm; 2008 Apr; 57(2):99-102. PubMed ID: 18578420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral hyposensitization (author's transl)].
    Ebner H
    Wien Klin Wochenschr Suppl; 1980; 117():19-21. PubMed ID: 6936977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro and contra of specific hyposensitization.
    Karl S; Ring J
    Eur J Dermatol; 1999 Jun; 9(4):325-31. PubMed ID: 10356415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grass pollen hyposensitization versus placebo therapy.
    Weyer A; Heritier CL; David B
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):101-7. PubMed ID: 6354089
    [No Abstract]   [Full Text] [Related]  

  • 30. [Every tenth person has hay fever complaints. To whom do you advise hyposensitization?].
    Ring J
    MMW Fortschr Med; 2004 Sep; 146(37):12. PubMed ID: 15887694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Allergic rhinitis. Treating symptoms or desensitization?].
    MMW Fortschr Med; 2003 Jan; 145(5):52. PubMed ID: 12619217
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complex histaglobin and allergoid therapy of seasonal allergic diseases of the upper respiratory tract].
    Giusan AO; Karpov VP
    Vestn Otorinolaringol; 1983; (2):68-9. PubMed ID: 6190297
    [No Abstract]   [Full Text] [Related]  

  • 34. The significance of testing and hyposensitization with several grass pollens for hay fever.
    Heijer A; Göransson K
    Acta Allergol; 1968 May; 23(2):146-60. PubMed ID: 5755560
    [No Abstract]   [Full Text] [Related]  

  • 35. [Characteristics of pollinoses in the Crimea and the effectiveness of specific hyposensitization].
    Selivanova KF; Alekseĭchuk AM; Ponomarenko LP; Baranovskaia TK; Baklazhova NK
    Vrach Delo; 1983 May; (5):82-5. PubMed ID: 6224349
    [No Abstract]   [Full Text] [Related]  

  • 36. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 37. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
    Canonica GW; Passalacqua G
    Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sublingual immunotherapy].
    Nelken D
    Harefuah; 1996 Sep; 131(5-6):164-5, 215. PubMed ID: 8940498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The status of hyposensitization therapy in allergic disease.
    Vanselow NA
    Univ Mich Med Cent J; 1968; 34(3):137-42. PubMed ID: 4874133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.